Prophylactic use of laxative for constipation in critically ill patients

被引:29
|
作者
Masri, Yasser [2 ]
Abubaker, Jawed [1 ]
Ahmed, Raees [1 ]
机构
[1] Rashid Hosp, Ctr Trauma, Med Intens Care Unit, Dubai, U Arab Emirates
[2] Rashid Hosp, Ctr Trauma, Dept Crit Care Med, Surg Intens Care Unit, Dubai, U Arab Emirates
关键词
Constipation; critically ill patients; prophylaxis; METHYLNALTREXONE;
D O I
10.4103/1817-1737.69113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: This study was designed to evaluate the use of laxative prophylaxis for constipation in intensive care unit (ICU) and the impact of early versus late bowel movement on patient's outcome. METHODS: The study was a prospective, randomized controlled trial in critically ill ventilated adult patients, who were expected to stay on ventilator for >72 h. Control group did not receive any intervention for bowel movement for the first 72 h, whereas interventional group received prophylactic dose of lactulose 20 cc enterally every 12 h for the first 72 h. The parameters measured during the study were admission diagnosis, age, gender, comorbid conditions, admission Simplified Acute Physiologic Score (SAPS II), sedative and narcotic agents with doses and duration, timing and tolerance of nutrition, daily assessment of bowel movement, total use of prokinetic, doses of suppositories, and enema for first bowel movement, total number of days on ventilator, weaning failures, extubation or tracheostomy, ICU length of stay, and death or discharge. RESULTS: A total of 100 patients were enrolled, 50 patients in each control and interventional group. Mean age was 38.8 years, and both groups had male predominance. Mean SAPS II score for both was 35. Mean dose of Fentanyl (323.8 +/- 108.89 mcg/h in control and 345.83 +/- 94.43 mcg/h in interventional group) and mean dose of Midazolam (11.1 +/- 4.04 mg/h in control and 12.4 +/- 3.19 mg/h in interventional group). There were only two (4%) patients in control, while nine (18%) patients in interventional group who had bowel movement in <72 h (P<0.05). Mean ventilator days were 16.19, and 17.36 days in control and interventional groups, respectively. Subgroup analysis showed that the patients who moved bowel in <5 days in both groups had mean ventilator days of 18.5, whereas it was 15.88 days for the patients who moved bowel after 5 days in both groups (P<0.05). Mean ICU days for control was 21.15 +/- 10.44 and 20.77 +/- 8.33 days for interventional group. Forty-eight (96%) patients in each group were discharged from the ICU. Two (4%) patients died in ICU in each group. CONCLUSIONS: Laxative prophylaxis can be used successfully to prevent constipation in ICU patients. Late
引用
收藏
页码:228 / 231
页数:4
相关论文
共 50 条
  • [31] Prophylactic use of platelets in critically ill patients with thrombocytopaenia: A retrospective two-centre observational study
    O'Bryan, Liam J.
    Bedford, Jonathan
    Redfern, Oliver C.
    Hatch, Robert A.
    Young, J. Duncan
    Watkinson, Peter J.
    [J]. JOURNAL OF CRITICAL CARE, 2020, 57 : 157 - 167
  • [32] The impact of laxative use upon symptoms in patients with proven slow transit constipation
    Dinning, Phil G.
    Hunt, Linda
    Lubowski, David Z.
    Kalantar, Jamshid S.
    Cook, Ian J.
    Jones, Mike P.
    [J]. BMC GASTROENTEROLOGY, 2011, 11
  • [33] Severe hyperkalemia in critically ill patients treated with prophylactic doses of enoxaparin
    Danguy, Christine
    Biston, Patrick
    Carlier, Eric
    Defrance, Pierre
    Piagnerelli, Michael
    [J]. INTENSIVE CARE MEDICINE, 2012, 38 (11) : 1904 - 1905
  • [34] Prophylactic Minocycline for Delirium in Critically Ill Patients A Randomized Controlled Trial
    Dal-Pizzol, Felipe
    Coelho, Andre
    Simon, Carla S.
    Michels, Monique
    Corneo, Emily
    Jeremias, Aline
    Damasio, Danusa
    Ritter, Cristiane
    [J]. CHEST, 2024, 165 (05) : 1129 - 1138
  • [35] Prophylactic Enoxaparin in Critically Ill Trauma Patients: Evaluation of the Initial Dose
    Agedal, Kaitlyn J.
    Feldman, Elizabeth A.
    Seabury, Robert W.
    Darko, William
    Probst, Luke A.
    Miller, Christopher D.
    Cwikla, Gregory M.
    [J]. HOSPITAL PHARMACY, 2022, 57 (04) : 540 - 545
  • [36] Severe hyperkalemia in critically ill patients treated with prophylactic doses of enoxaparin
    Christine Danguy
    Patrick Biston
    Eric Carlier
    Pierre Defrance
    Michael Piagnerelli
    [J]. Intensive Care Medicine, 2012, 38 : 1904 - 1905
  • [37] Use of noninvasive ventilation in critically ill patients
    Valko Luca
    Baglyas Szabolc
    Tamaska Eszter
    Lorx Andras
    Gal Janos
    [J]. ORVOSI HETILAP, 2018, 159 (45) : 1831 - 1837
  • [38] THE USE OF SEDATIVE AGENTS IN CRITICALLY ILL PATIENTS
    BURNS, AM
    SHELLY, MP
    PARK, GR
    [J]. DRUGS, 1992, 43 (04) : 507 - 515
  • [39] The use of fentanyl in critically ill patients in ICU
    Tourkochoriti, L
    Karabatsos, E
    Zidianakis, V
    Filippatos, G
    Ikonomou, E
    Baltopoulos, G
    [J]. 1ST MEDITERRANEAN CONGRESS ON INTERVENTIONAL DIAGNOSIS FOR THORAX DISEASES, 1996, : 469 - 472
  • [40] The use and risks of antibiotics in critically ill patients
    Denny, Kerina J.
    Cotta, Menino O.
    Parker, Suzanne L.
    Roberts, Jason A.
    Lipman, Jeffrey
    [J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 667 - 678